tamoxifen
Selected indexed studies
- Tamoxifen and pregnancy. (Breast, 2004) [PMID:15563850]
- Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics. (Adv Pharmacol, 2018) [PMID:29801584]
- [Tamoxifen, a high-potential molecule to treat all centronuclear myopathies]. (Med Sci (Paris), 2024) [PMID:39555875]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tamoxifen and pregnancy. (2004) pubmed
- Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics. (2018) pubmed
- [Tamoxifen, a high-potential molecule to treat all centronuclear myopathies]. (2024) pubmed
- The tamoxifen controversy. (1996) pubmed
- Tamoxifen and Fertility in Women with Breast Cancer: A Systematic Review on Reproductive Outcomes and Oncological Safety of Treatment Interruption. (2025) pubmed
- Tamoxifen. (1993) pubmed
- Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications. (2015) pubmed
- Tamoxifen in men: a review of adverse events. (2016) pubmed
- Tamoxifen and the female reproductive tract. (2001) pubmed
- Tamoxifen and its new derivatives in cancer research. (2011) pubmed